GLP-1 receptor agonists are FDA-approved for weight loss and type 2 diabetes
Due to its versatility, it has become a key compound in the realm of regenerative medicine
Should future research validate its advantages, it may eventually be utilized in conjunction with stem cell therapy, tailored scaffolds, or alternative biomaterials to augment healing [4][3]
The secondary outcome measurements were improvement of neurologic symptoms and hematologic findings (serum folate, homocysteine, ferritin, iron, total iron binding capacity, transferrin, and mean corpuscular volume)
Both GHK-Cu and BPC-157 have no sex-specific mechanisms and have been studied across both sexes in preclinical models